Garth Rapeport

Respiratory Infections, Aspergillosis, Aspergillus, RSV, PC945, Drug Discovery

Garth Rapeport
Not reviewed
Contact information
Garth Rapeport is the founder and CEO of Pulmocide, an innovative venture capital funded company that specialises in tackling prevalent, but hard-to-treat respiratory infections.

The company focuses on infections associated with life-threatening...

Contact information

Garth Rapeport
Pulmocide Ltd
52 Princes Gate
  SW7 2PG London
United Kingdom

Opening hours

Callback request Write a message
Submit a review
Tell a friend

Your message to Garth Rapeport

Please complete the field highlighted in red.
Please complete the field highlighted in red.
Invalid email address
* required fields
Invalid characters. Only numbers and space characters are possible.

I accept the privacy policy.

Profile active since 05/23/2019  |  Last update: 05/23/2019   |  Report profile
Review Guidelines  |  Quality Assurance  |  Privacy Policy  |  Legal Notice  © 2011 - 2020 Expert Systems GmbH
By using our website you agree to the use of cookies. Learn moreOK